Global Bifurcation Lesions Market – Industry Trends and Forecast to 2029

Market Analysis and Size

The chance of acquiring bifurcation lesions is growing as the incidence of coronary artery disease (CAD) rises. This is one of the most important reasons for boosting industry expansion. In addition, the market is being bolstered by the approval of novel technologies, increased insurance coverage, and improved imaging modalities.

Data Bridge Market Research analyses that the bifurcation lesions market which was USD 2,671.78 million in 2021, would rocket up to USD 4194.56 million by 2029, and is expected to undergo a CAGR of 5.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation      

Market Definition

The constriction of the coronary artery near to the origin of a substantial side branch is known as a bifurcation lesion (SB). Due to turbulent blood flow and high shear stress, it is more likely to generate atherosclerotic plaque. Analysis, procedure time, X-ray exposure, and long-term follow-up are all used to treat it. The bifurcation angles are also measured using three-dimensional (3D) angiography and multi-slice computed tomography. The management of difficult cases of bifurcation lesions is becoming possible worldwide thanks to developments in equipment, imaging, supplementary medication, and vascular access.

Bifurcation Lesions Market Dynamics

Drivers

• Rise in geriatric population

The rising frequency of cardiovascular illnesses is due to the growing senior population and an unhealthy lifestyle. Furthermore, the market is predicted to be driven by a growth in the approval and commercialization of innovative devices and the expected entrance of new devices for the treatment of bifurcation lesions in the next years.

• Demand for minimally invasive (MI) procedures

The market is being supported by the growing senior population, which is more likely to acquire medical problems and supportive measures conducted by governments of various nations for reimbursement. Other factors driving market expansion include rising medical tourism, rising demand for minimally invasive (MI) procedures, and improving healthcare infrastructure. Aside from that, the market is being driven by ongoing research into novel treatment procedures.

• Research and developments

Researchers are looking into the efficacy of the Szabo 2-stent approach for complex bifurcation lesions with a high risk of compromise or fatal SB occlusion. Furthermore, a large number of clinical trials on stents and balloons, together with an increase in the number of qualified healthcare professionals, are expected to reduce the risks associated with bifurcation lesions treatment and positively benefit the market.

Opportunities

The current increase in the incidence of cardiovascular diseases appearing at a young age is due to the growing geriatric population and bad lifestyle choices. Furthermore, during the projection period of 2022-2029, the market is expected to be driven by an increase in the endorsement and commercialization of innovative devices and the normal section of new devices for the treatment of bifurcation lesions.

Restraints/Challenges

However, certain factors like high treatment costs and reimbursement issues are restraining the market growth of bifurcation lesions during the forecast period.    

This bifurcation lesions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bifurcation lesions market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Bifurcation Lesions Market

In 2020, the COVID-19 pandemic will substantially impact the global bifurcation lesions market. COVID-19 has had a wide range of consequences, including aircraft cancellations, travel bans and quarantines, restaurant closures, and restrictions on all indoor and outdoor events. Over fifty countries have declared a state of emergency, resulting in a major drop in economic confidence, rising public panic, and uncertainty about the future. All of these factors have had a significant impact on production, supply chain management, shipping, import and export, and other market operations. The paper will detail the direct and indirect effects of the pandemic on the market.

Global Bifurcation Lesions Market Scope

The bifurcation lesions market is segmented on the basis of policy type, animal type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

????

• ?n?-?t?nt
• ?w?-?t?nt

???l???t??n

• ??r?n?r? V???ul?r
• ??r??h?r?l V???ul?r

Bifurcation Lesions Market Regional Analysis/Insights

The bifurcation lesions market is analysed and market size insights and trends are provided by country, policy type, animal type and end-user as referenced above.

The countries covered in the bifurcation lesions market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominating the bifurcation lesions market. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and the local presence of major market players.

The Asia-Pacific is expected to observe the fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and a rise in investments by market players in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Bifurcation Lesions Market Share Analysis

The bifurcation lesions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bifurcation lesions market.

Some of the major players operating in the bifurcation lesions market are:

• Abbott (U.S)
• Boston Scientific Corporation (U.S)
• Cardinal Health (U.S)
• Medtronic (Ireland)
• Johnson & Johnson private ltd. (U.S)
• C. R. Bard, Inc. (U.S)
• Philips Healthcare (U.S)
• Terumo Medical Corporation (Japan)
• Tryton Medical, Inc. (U.S)
• Stryker (U.S)
• Tecomet, Inc. (U.S)
• Olympus Corporation (Japan)
• Eurocor Tech GmbH (Germany)
• Absolute-DSi.com (U.S)
• B Braun Melsungen AG (Germany)

SKU-68436